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Background: Fulminant type 1 diabetes is a non-autoimmune disorder characterized by sudden onset. This
complication is rarely associated with myocarditis, suggesting an involvement of viral infection. We report a patient
with myocarditis who was admitted for fulminant type 1 diabetes and diagnosed using a combination of non-
invasive techniques.
Case presentation: We describe the case of a 25-year-old Japanese man with fulminant type 1 diabetes
complicated by myocarditis. The patient was admitted with flu-like symptoms and diabetic ketoacidosis, followed
by chest pain the next day. Myocardial damage was suspected based on ST-segment elevation on
electrocardiogram and elevation of cardiac enzymes. However, coronary angiography revealed no abnormality in
the coronary arteries. We diagnosed myocarditis by a combination of echocardiography, cardiovascular magnetic
resonance imaging (CMR), as well as Thallium-201 and Iodine-123 beta-methyl iodophenyl pentadecanoic acid
(Tl-201 BMIPP and I-123 BMIPP) and myocardial imaging. More importantly, CMR revealed diffuse enhancement in
the subepicardium of the left ventricle with late gadolinium enhancement, consistent with myocardial edema. The
patient was successfully treated, received a two-week education program on diabetes and discharged without
complication.
Conclusions: The rapid onset and flu-like symptoms strongly suggest the involvement of viral infection in the
pathogenesis of fulminant type 1 diabetes and myocarditis. While cardiac muscle biopsy is routinely performed, this
case demonstrates that a combination of non-invasive techniques, especially CMR, may successfully diagnose
myocarditis in patients with fulminant type 1 diabetes.
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Fulminant type 1 diabetes is a new subtype of diabetes
characterized by a markedly rapid progression, an almost
complete destruction of pancreatic beta cells, abnormal
autoimmune response, and elevated pancreatic enzymes in
the serum. While the precise mechanism of beta-cell
destruction is unknown, the mononuclear cell infiltrations,
detected in endocrine and exocrine pancreas, suggest an* Correspondence: katsuhiromakino@gmail.com
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reproduction in any medium, provided the orassociation with viral infection [1]. We report a rare case of
fulminant type 1 diabetes complicated by myocarditis.Case presentation
A 25-year-old man consulted a local hospital for disturbed
consciousness. His medical and family histories were unre-
markable, except for glaucoma during childhood. He had
been healthy until an episode of flu-like symptoms that
occurred 5 days before admission. He lived alone, and had
not been in touch with anybody for days. At the time of
admission, he had hypothermia (27.8°C), elevated blood
glucose (1049 mg/dl), and ketonuria. Blood gas analysisLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Coronary angiography. Absence of stenotic or obstructed lesions
Caudal 45°) (b) Caudal (LAO 0°, Caudal 30°) (c) Right anterior oblique caudal (
Table 1 Baseline blood composition
Parameter Concentration Parameter Concentration
White blood
cells
17,000/mm3* Total protein 5.1 g/dL*
Hematocrit 37.0%* Albumin 3.0 g/dL*
Hemoglobin 12.6 g/dL* Aspartate
aminotransferase
156 IU/L*
Platelets 180,000 /mm3 Alanine
aminotransferase
63 IU/L*
HbA1c 6.4% Lactate dehydrogenase 543 IU/L*
Anti-GAD
antibody
5.3 U/mL* Creatinine kinase 1753 IU/L*
Anti-IA-2
antibody
<0.4 U/mL Creatinine kinase-MB 161 IU/L*
Fasting C-
peptide
<0.03 ng/mL* Troponin I 18.2 ng/m*L








GAD glutamic acid decarboxylase.
*, parameters not in the normal range.
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metabolic abnormalities. He was diagnosed with diabetic
ketoacidosis, and intravenous infusions of insulin and
fluids were initiated.
The next day, the patient complained of chest pain. Since
an ST-segment elevation was detected on the electrocar-
diograph, acute myocardial infarction was suspected.
Therefore, he was transferred to our hospital. Physical find-
ings included blood pressure, 122/64 mmHg; pulse, 95
beats/min; and temperature, 36.6°C. Pancreatic and liver
enzymes were elevated. Conversely, the phosphorus level
was low (1.0 mmol/L), whereas HbA1c was 6.4%, and C-
peptide was undetectable in plasma (Table 1). Abdominal
computed tomography revealed no abnormalities. To-
gether, the symptoms of elevated blood glucose, near
normal HbA1c, ketoacidosis, and low C-peptide level at
disease onset were consistent with fulminant type 1
diabetes mellitus.
Electrocardiogram analysis showed ST-segment elevation
in II, III, aVf, and V4–6. The cardiac enzymes were elevated.
Echocardiography revealed diffuse hypokinesis of the left
ventricle wall, and the ejection fraction was 45.3%. Coron-
ary angiography did not detect any stenotic or obstructive
lesions in the coronary arteries (Figure 1). The chest pain
disappeared on the same day. On Day 3 of hospitalization,
CMR revealed diffuse gadolinium myocardial enhancementin the coronary arteries. (a) Left anterior oblique caudal (spider, LAO 45°,
RAO 30°, Caudal 30°) (d) Left anterior oblique (LAO 50°, Caudal 0°).
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with myocardial edema (Figure 2). Dual SPECT imaging
using Tl-201 BMIPP and I-123 BMIPP showed that the
defects were not restricted to a specific area in the heart
(Figure 3). These findings supported the diagnosis of
acute myocarditis.
The possibility of an infection was investigated using
viral antibodies against influenza A and B; echovirus 3,
7, and 9; adenovirus; coxsackie A2, 9, 16, and B1-6; cyto-
megalovirus; and mumps. The serum antibody titer for
coxsackie B4 was 64 at the time of admission, and had
decreased to 32 one month later, suggesting a viral
involvement in the disease.
The patient was treated by carperitide and phosphorus
infusions for mild heart failure and hypophosphatemia,
respectively. Echocardiography performed on Day 10
showed no wall motion asynergy, and the ejection
fraction recovered to 62.1%. On Day 5, intravenous
insulin infusion was stopped (Figure 4), and insulin
was administered subcutaneously at a scheduled time.
The patient learned how to monitor blood glucose
and inject insulin. After adjusting the dose of insulin,
the patient received a two-week inpatient education
program on diabetes mellitus. Then, he was discharged
29 days after admission.Figure 2 Cardiovascular magnetic resonance imaging. (a) T2-weighted
(b–d) Late gadolinium enhancement showing subepicardial enhancementDiscussion
Fulminant type 1 diabetes is a non-autoimmune disorder
characterized by a remarkably acute onset. In most
cases, the initial symptoms are flu-like symptoms,
elevated pancreatic enzymes, the absence of islet-related
autoantibodies, and a dramatic decrease in beta cells and
alpha cells. A nationwide survey determined this variant
accounts for ~ 20% of all patients with acute-onset type
1 diabetes in Japan. However, its association with myo-
carditis has rarely been reported. A Japanese survey
revealed the involvement of viral infection, namely the
coxsackie virus (types A4, 5, 6, and B1), rotavirus, cyto-
megalovirus, EB virus, HHV-6 and HHV-7. Cases of islet
infiltrations with macrophages and T cells, as well as en-
terovirus RNA and Toll-like receptor-3 expression have
been reported. Therefore, it has been suggested that viral
infection may contribute to the development of this sub-
type of diabetes and trigger an anti-viral immune response
[1,2]. Since our patient reported flu-like symptoms 5 days
before admission, and exhibited a 2-fold decrease in
coxsackie virus titer one month later, an infection-related
onset of the disease is a possibility.
We considered myocarditis or Takotsubo cardiomyop-
athy because of the clinical symptoms of heart failure,
evidence of cardiac functional perturbation, and presenceimaging showing enhancement in the septum and posterior wall.
in the septal, anterolateral, and posterior walls.
Figure 3 Dual SPECT imaging using Tl-201 and I-123 beta-methyliodophenyl pentadecanoic acid (BMIPP). Widespread distribution of
tissue anomalies in the myocardium.
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induced by stress and excess catecholamines, shows a
similar clinical course as myocarditis. However, this option
was ruled out because of the widespread defects detected
in the myocardium by echocardiography and dual SPECT
imaging [3-5]. First, Takotsubo cardiomyopathy usually af-
fects the apical and midventricular myocardium, but does
not cause diffuse hypokinesis. Second, the patchy diffuse
distribution within the subepicardium on CMR is pathog-
nomonic for myocarditis, whereas Takotsubo cardiomyop-
athy is generally not associated with late gadoliniumenhancement [6]. Lastly, stress-induced cardiomyopathy
causes milder elevations in cardiac enzyme levels than
recorded in our patient [2]. On the basis of these findings,
we diagnosed myocarditis. This combination of non-
invasive imaging techniques reduces the need for a myo-
cardial biopsy to diagnose myocarditis.
Mechanistically, the evidence accumulated thus far
suggests that the onset of fulminant type 1 involves an
immune reaction to an enterovirus. The viral infection
would induce a self-perpetuating cycle of cytokine/
chemokine overexpression in pancreatic beta cells,
Figure 4 Clinical course of imaging techniques and laboratory results. The patient received insulin/insulin detemir treated and a low calory
diet. He was monitored for serum phosphocreatine (CPK), troponin I (TnI), phosphorus (P), white blood cell counts (WBC), liver aspartate
transaminase (AST), liver alanine transaminase (ALT) and glucose (Glu).
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also commonly induced by viral infections, including the
coxsackie virus B [8]. The viruses replicate in the gut
and spleen, then spreads to the heart. Their replication
in the myocardium causes tissue damage amplified by an
autoimmune response, leading to heart failure. There-
fore, the concomitant fulminant type 1 diabetes and
myocarditis exhibited by our patient may share a com-
mon etiology.
Conclusion
Viral infections, drugs, toxins, and systemic diseases lead
to myocarditis. The absence of drugs and toxins in this
patient’s medical history, and the preceding flu-likesymptoms, suggest that a viral infection precipitated
both fulminant type 1 diabetes and myocarditis. The
present case also illustrates that a combination of non-
invasive techniques, including CMR, may adequately
diagnose myocarditis in patients with fulminant type 1
diabetes, even in the absence of cardiac muscle biopsy.
Consent
Written informed consent was obtained from the pa-
tient for the publication of this Case report and any
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form is available for review from the editor of this
journal.
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